A Study Investigating Intravenous Human Normal Immune Globulin 10% in Adults With Stiff Person Syndrome | MicrobiomeTrials← Back to trialsNCT07552987
A Study Investigating Intravenous Human Normal Immune Globulin 10% in Adults With Stiff Person Syndrome
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-09Est. Completion: 2028-01
Enrollment target: 38 participants Other microbiome trials you might be interested in
Lupus NephritisAutoimmune DiseasesSystemic Sclerosis (SSc)Systemic Lupus Erythematosus (SLE)ANCA-Associated Vasculitis (AAV)Idiopathic Inflammatory MyopathiesStiff Person Syndrome
ADI-202300103 is a phase 1 multicenter, open label, dose finding and dose expansion, safety/efficacy study in patients w…
Redwood City, United StatesCompleted Dec 2026
Autoimmune DiseaseNeurologic Autoimmune Disease
Autologous Transplant Autoimmune
Multiple Sclerosis Transplant
MS Stem Cell Transplant
Multiple Sclerosis Stem Cell Transplant
Stiff Person Syndrome
HCT for Neurologic Autoimmune Disorders
CIDP Transplant
Myasthenia Gravis Transplant
Autoimmune Nervous System Disorder
Central Nervous System Vasculitis
Cerebellar Degeneration
Chronic Inflammatory Demyelinating Polyneuropathy
Lambert Eaton Myasthenic Syndrome
Myasthenia Gravis
Neuromyelitis Optica
Opsoclonus Myoclonus Syndrome
Rasmussen Subacute Encephalitis
This phase II trial studies the side effects and how well carmustine, etoposide, cytarabine and melphalan together with …
Denver, United StatesEst. completion Dec 30, 2025